<DOC>
	<DOCNO>NCT00609544</DOCNO>
	<brief_summary>Anemia inflammation common complication patient chronic kidney disease ( CKD ) . Patients CKD anemia inflammation also exhibit decreased response erythropoietic agent , even presence adequate iron store . This decreased responsiveness associate increased level proinflammatory cytokine . Rilonacept develop treatment inflammatory disorder . This clinical research study determine safety effectiveness rilonacept treatment anemia inflame patient CKD yet dialysis .</brief_summary>
	<brief_title>Study Safety Effectiveness Rilonacept ( IL-1 Trap ) Administered Subcutaneously Subjects With Non Dialysis-Dependent Chronic Kidney Disease ( NDD-CKD ) Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Male female great 18 year age Chronic Kidney Disease ( CKD ) yet require renal replacement therapy ( predialysis patient ) Not expect require dialysis duration study Adequate laboratory value If rHuEPO therapy , dose must stable Persistent chronic active infection Intravenous ( IV ) iron administration within 12 week prior Screening Visit Known history severe uncontrolled hyperparathyroidism Prior recipient schedule receive kidney transplant study Abnormal laboratory value Unstable angina myocardial infarction within past 6 month prior Screening Visit Uncontrolled hypertension Coronary disease diagnose 3 month prior Screening Visit Severe Congestive Heart Failure History HIV Hepatitis B and/or Hepatitis C Abnormal chest radiograph A positive intradermal skin tuberculin test History presence cancer within 5 year Screening Visit History alcohol abuse current intake 21 alcoholcontaining drink per week History drug abuse within 5 year prior Screening Visit Lactating female pregnant female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Non Dialysis-dependent chronic kidney disease anemia</keyword>
</DOC>